About the forum
The CBE JU Stakeholder Forum 2026 will bring together around 400 stakeholders from across Europe to discuss how to turn high-potential bio-based innovations into competitive, large-scale industrial solutions. Discussions will focus on three key challenges: scaling up innovations, enabling market uptake and financing, and strengthening Europe’s industrial leadership.
The forum is particularly timely, as the EU prepares to launch the Biotech II Act and the Circular Economy Act, and roll out the updated Bioeconomy Strategy.
The event will include panel discussions, an exhibition of more than 40 bio-based products, and many opportunities to exchange with industry leaders, policymakers, researchers, primary producers, and regional representatives.
- Explore the event’s agenda, the exhibition, and learn more about the speakers.
- Take a look at the press release announcing the event.
Quote:
“The circular bio-based sector is of tremendous strategic importance for the European Union. By reducing dependence on fossil imports, it strengthens Europe’s strategic autonomy. By fostering innovation and market opportunities, it boosts economic competitiveness across regions. And by supporting the transition to sustainable growth, it contributes to the EU’s climate goals. I look forward to the discussions with Europe’s leading voices on the critical challenge ahead: turning high-potential bio-based innovations into large-scale industrial solutions.”
Nicoló Giacomuzzi-Moore, CBE JU Executive Director
Media contact: press [at] cbe.europa.eu
About CBE JU
The Circular Bio-based Europe Joint Undertaking (CBE JU) is a €2 billion partnership between the European Union and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bio-based industries in Europe. The partnership has so far invested a total of €1.3 billion in 220 projects scaling up Europe’s circular bio-based innovations. Every euro of public funding is attracting €3.5 in private investment in the CBE JU programme.
CBE JU is operating under the rules of Horizon Europe, the EU’s research and innovation programme, for the 2021-2031 period.